German (DAX) Pharma Industry Analysis
UpdatedJan 31, 2023
DataAggregated Company Financials
Companies9
- 7D0.9%
- 3M12.7%
- 1Y0.6%
- YTD10.1%
The Pharma industry has stayed flat over the last week. In line with that, the industry has also been flat over the past 12 months. Earnings are forecast to grow by 7.7% annually.
Industry Valuation and Performance
Has the German Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 31 Jan 2023 | €142.7b | €72.8b | €8.4b | 15x | 17.1x | 2x |
| Thu, 29 Dec 2022 | €129.3b | €72.8b | €8.4b | 14.9x | 15.4x | 1.8x |
| Sat, 26 Nov 2022 | €134.0b | €72.8b | €8.4b | 17x | 16x | 1.8x |
| Mon, 24 Oct 2022 | €121.1b | €70.5b | €7.8b | 13.1x | 15.6x | 1.7x |
| Wed, 21 Sep 2022 | €125.8b | €70.5b | €7.8b | 15.3x | 16.2x | 1.8x |
| Fri, 19 Aug 2022 | €135.7b | €70.5b | €7.8b | 13.7x | 17.4x | 1.9x |
| Sun, 17 Jul 2022 | €133.9b | €67.8b | €5.6b | 23.8x | 23.8x | 2x |
| Tue, 14 Jun 2022 | €138.2b | €67.8b | €5.6b | 22.9x | 24.6x | 2x |
| Thu, 12 May 2022 | €134.1b | €67.2b | €5.5b | 24.1x | 24.4x | 2x |
| Sat, 09 Apr 2022 | €150.7b | €64.8b | €4.2b | 29.6x | 35.8x | 2.3x |
| Mon, 07 Mar 2022 | €130.4b | €63.7b | €3.4b | 27.9x | 38x | 2x |
| Wed, 02 Feb 2022 | €143.1b | €63.1b | €3.1b | 31.8x | 46.7x | 2.3x |
| Fri, 31 Dec 2021 | €150.3b | €63.1b | €3.1b | 36x | 49x | 2.4x |
| Sun, 28 Nov 2021 | €146.7b | €63.1b | €3.1b | 36.9x | 47.9x | 2.3x |
| Tue, 26 Oct 2021 | €140.9b | €61.2b | -€4,717,516,252.00 | 38.8x | -29.9x | 2.3x |
| Thu, 23 Sep 2021 | €137.0b | €61.2b | -€4,716,670,252.00 | 31.5x | -29x | 2.2x |
| Sat, 21 Aug 2021 | €140.9b | €61.2b | -€4,716,670,252.00 | 32.8x | -29.9x | 2.3x |
| Sat, 05 Jun 2021 | €119.1b | €59.6b | -€12,511,451,517.00 | 32.3x | -9.5x | 2x |
| Tue, 09 Mar 2021 | €111.3b | €59.8b | -€13,556,792,870.00 | 29.4x | -8.2x | 1.9x |
| Mon, 30 Nov 2020 | €109.1b | €60.3b | -€14,034,964,373.38 | 30.9x | -7.8x | 1.8x |
| Thu, 03 Sep 2020 | €106.9b | €61.3b | -€5,793,814,704.00 | 31.3x | -18.4x | 1.7x |
| Sun, 07 Jun 2020 | €107.2b | €61.7b | €4.3b | 29.9x | 25.1x | 1.7x |
| Sat, 29 Feb 2020 | €113.7b | €60.5b | €3.8b | 26.6x | 30.1x | 1.9x |
Price to Earnings Ratio
33x
Current Industry PE
- Investors are optimistic on the German Pharmaceuticals industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 16.8x which is higher than its 3-year average PE of 8.1x.
- The industry is trading close to its 3-year average PS ratio of 2.0x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 30% per year over the last three years.
- Revenues for these companies have grown 6.4% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the German Healthcare industry?
| DE Market | 0.26% | |
| Healthcare | 0.31% | |
| Pharma | 0.89% | |
| Pharma | 0.89% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| BAYN Bayer | €56.90 | 1.7% +€923.5m | 5.7% | PE11.9x | |
| MRK MERCK Kommanditgesellschaft auf Aktien | €193.55 | 0.4% +€369.6m | -0.2% | PE24.2x | |
| 93M1 MPH Health Care | €15.10 | 2.7% +€1.7m | -39.1% | PB0.4x | |
| HIGH Cantourage Group | €10.36 | 0.4% +€475.0k | n/a | n/a | |
| SBX SynBiotic | €11.30 | 0.7% +€293.9k | -50.4% | PS4.6x |